Key result
Silent brain infarction in rheumatic mitral stenosis is linked to ~3.4-fold higher stroke/TIA risk.
Why the study?
Does baseline silent brain infarction predict subsequent stroke or transient ischemic attack in adults with moderate-to-severe rheumatic mitral stenosis?
Cohort (n=211)
Does baseline silent brain infarction predict subsequent stroke or transient ischemic attack in adults with moderate-to-severe rheumatic mitral stenosis?
Silent brain infarction is common in moderate-to-severe rheumatic mitral stenosis regardless of atrial fibrillation status and independently predicts a more than threefold higher odds of subsequent clinical stroke or TIA, while elevated BNP predicts both SBI and mortality.
Answers are grounded in this paper and cite their sources.
May identify higher-risk rheumatic mitral stenosis patients; hypothesis-generating for MRI-based stratification pending prospective trials.
Rheumatic mitral stenosis (MS) affects a relatively young population. Thromboembolic risk in MS is traditionally attributed to atrial fibrillation (AF), although silent brain infarction (SBI) may occur in sinus rhythm. Further, the contribution of underlying atrial disease independent of rhythm remains uncertain. To determine the prevalence and correlates of SBI and evaluate associations with subsequent cerebrovascular and clinical outcomes. In this prospective cohort, 211 adults with moderate-to-severe rheumatic MS underwent baseline brain MRI, echocardiography, biomarker assessment, and rhythm evaluation. Firth penalized logistic regression was used for SBI and longitudinal outcomes. Clinical follow-up was available in 194 patients. SBI was present in 44 patients (20.9%). SBI occurred in 25.4% with AF and 18.6% in sinus rhythm (unadjusted OR 1.49, 95% CI 0.70-3.10; p = 0.284); adjusted AF was not significantly associated with SBI (OR 0.82, 95% CI 0.37-1.76; p = 0.605). Each doubling of BNP was associated with SBI overall (OR 1.34, 95% CI 1.01-1.82; p = 0.040) and in sinus rhythm (OR 1.56, 95% CI 1.12-2.27; p = 0.007). During follow-up, 15 patients developed stroke/TIA; baseline SBI was associated with subsequent stroke/TIA (17.1% vs 5.2%; adjusted OR 3.40, 95% CI 1.14-9.96; p = 0.029). BNP was associated with stroke/death (49 events; OR per doubling 1.45, 95% CI 1.09-2.00; p = 0.010) and death (40 events; OR 1.57, 95% CI 1.14-2.25; p = 0.005), but not stroke/TIA. SBI is common in rheumatic MS and identifies patients at higher subsequent cerebrovascular risk. BNP is associated with SBI and broader adverse prognosis, particularly mortality. These findings are hypothesis-generating and require further validation.
No takes yet. Share an insight, caveat, or question.
Naik et al. (2026) conducted a cohort in Moderate-to-severe rheumatic mitral stenosis (n=211). Baseline silent brain infarction (SBI) vs. Absence of silent brain infarction was evaluated on Subsequent stroke or transient ischemic attack (TIA) (OR 3.40, 95% CI 1.14-9.96, p=0.029). Baseline silent brain infarction in rheumatic mitral stenosis was associated with higher subsequent stroke/TIA.
Synapse has enriched 10 related papers. Consider them for comparative context: